Anti-epileptic Agent class drugs

4 results

  • dilantin

    (Extended Phenytoin Sodium)
    Parke-Davis Div of Pfizer Inc
    DILANTIN is indicated for treating tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures, as well as for preventing and treating seizures that occur during or after neurosurgery.

  • felbatol

    (felbamate)
    Meda Pharmaceuticals Inc.
    Felbatol® is indicated for patients with severe epilepsy who do not respond to other treatments, allowing for its use despite risks of aplastic anemia and liver failure. It is used as monotherapy or adjunctive therapy for partial seizures in adults and for Lennox-Gastaut syndrome in children.

  • oxtellar xr

    (OXCARBAZEPINE)
    Supernus Pharmaceuticals, Inc.
    Oxtellar XR is indicated for the treatment of partial-onset seizures in patients aged 6 years and older.

  • sabril

    (vigabatrin)
    Lundbeck Pharmaceuticals LLC
    SABRIL is indicated as adjunctive therapy for adults and children (2+) with refractory complex partial seizures and as monotherapy for infants (1 month to 2 years) with infantile spasms, provided the benefits outweigh the risk of vision loss. It is not a first-line treatment for complex partial seizures.